Walgreens Boots Alliance has agreed to a $300 million settlement with the U.S. Justice Department to resolve allegations of unlawfully dispensing opioids and other controlled substances, with claims that the pharmacy chain filled millions of invalid prescriptions over more than a decade. The settlement, which could increase by $50 million if Walgreens undergoes a sale or merger before 2032, aims to address the role these practices played in the opioid crisis and prevent future occurrences. Despite the settlement, Walgreens denies any liability, with a spokesperson stating that the company disagrees with the government's legal theory and is settling to move past the legal challenges.
